Potential effects | AC1 KO | NB001 | hNB001 (present study) | Gabapentin |
---|---|---|---|---|
Contextual/Auditory fear memory | No change [15] | No change | N/A | |
Remote fear memory/extinction | No change (5 w/3 w) [32] | N/A | No change (30 d/30 d) | N/A |
Other types of memory | Spatial memory: impaired [44]; Trace fear memory: no change [42] | N/A | Trace fear memory: no change; Trace fear extinction: improved | Spatial memory: improved [45]; Inhibitory avoidance: a single treatment: improved [46], repeated treatment: impaired [40] |
LTP | ACC: blocked [5] Hippocampus: no change [15] | Hippocampus: no change [7] | ACC: blocked [24] | ACC: no change [37] Hippocampus: no change [36] |
Acute pain | No change [6] | No change [24] | ||
Chronic neuropathic pain | Alleviated [6] | Alleviated [24] | Alleviated [47] | |
Motor function | No change [34] | No change | No change [38] | |
Anxiety-like behavior | No change [35] | No change | Improved [45] |